Cullinan Therapeutics Ratios (2020-2026) | CGEM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)
EBIT Margin (Quarter)
EBITDA Margin (Quarter)
Operating Margin (Quarter)
Net Margin (Quarter)
FCF Margin (Quarter)
Efficiency
Assets Average (Quarter)	472.01M	458.88M	445.29M	437.32M	552.36M	642.24M	589.18M	538.05M	518.49M	508.35M	489.44M	466.81M	565.32M	667.24M	637.54M	600.75M	550.00M	502.23M	466.25M	425.68M
Asset Utilization Ratio (Quarter)			0.04
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-0.05	-10.88	-0.77	-10.42	65.97	-5.17	-0.70	-11.34	-7.41	-42.48	-0.52	-12.08	-16.42	-201.05	-0.42	-186.43	-430.67	-44.91	-0.01M	-19.50
Times Interest Earned (Quarter)	-0.05	-10.88	-0.77	-10.42	65.97	-5.17	-0.70	-11.34	-7.41	-42.48	-0.52	-12.08	-16.42	-201.05	-0.42	-186.43	-430.67	-44.91	-0.01M	-19.50
Dividends & Payouts
FCF Payout Ratio (Quarter)													-0.10	-0.02
Valuation
Enterprise Value (Quarter)	-333.71M	-318.96M	-290.06M	-552.87M	-868.35M	-575.95M	-467.29M	-390.70M	-841.76M	-867.98M	-466.88M	-433.01M	-662.50M	-1054.09M	-398.98M	-530.97M	-265.48M	-561.86M	-377.90M	-628.70M
Return Ratios
Return on Sales (Quarter)			-0.04%
Return on Capital Employed (Quarter)	-11.99%	-13.92%	-15.67%	-24.28%	31.47%	23.23%	25.53%	22.38%	-32.62%	-36.75%	-41.42%	-38.51%	-33.91%	-29.14%	-32.45%	-36.44%	-44.97%	-51.43%	-56.39%	-61.55%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	-0.01%